IMTX
Price
$4.24
Change
-$0.10 (-2.30%)
Updated
May 9 closing price
Capitalization
515.37M
9 days until earnings call
PHAT
Price
$3.14
Change
+$0.85 (+37.12%)
Updated
May 9 closing price
Capitalization
219.22M
87 days until earnings call
Ad is loading...

IMTX vs PHAT

Header iconIMTX vs PHAT Comparison
Open Charts IMTX vs PHATBanner chart's image
Immatics
Price$4.24
Change-$0.10 (-2.30%)
Volume$556.43K
Capitalization515.37M
Phathom Pharmaceuticals
Price$3.14
Change+$0.85 (+37.12%)
Volume$12.64M
Capitalization219.22M
IMTX vs PHAT Comparison Chart
Loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. PHAT commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a StrongBuy and PHAT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (IMTX: $4.24 vs. PHAT: $3.14)
Brand notoriety: IMTX and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 85% vs. PHAT: 729%
Market capitalization -- IMTX: $515.37M vs. PHAT: $219.22M
IMTX [@Biotechnology] is valued at $515.37M. PHAT’s [@Biotechnology] market capitalization is $219.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, IMTX is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 4 TA indicator(s) are bullish while PHAT’s TA Score has 4 bullish TA indicator(s).

  • IMTX’s TA Score: 4 bullish, 6 bearish.
  • PHAT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а -18.93% price change this week, while PHAT (@Biotechnology) price change was +13.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

IMTX is expected to report earnings on Aug 12, 2025.

PHAT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($515M) has a higher market cap than PHAT($219M). IMTX YTD gains are higher at: -40.366 vs. PHAT (-61.330). IMTX has higher annual earnings (EBITDA): -36.26M vs. PHAT (-272.12M). IMTX has more cash in the bank: 491M vs. PHAT (212M). IMTX has less debt than PHAT: IMTX (16M) vs PHAT (204M). IMTX has higher revenues than PHAT: IMTX (116M) vs PHAT (81.9M).
IMTXPHATIMTX / PHAT
Capitalization515M219M235%
EBITDA-36.26M-272.12M13%
Gain YTD-40.366-61.33066%
P/E Ratio26.79N/A-
Revenue116M81.9M142%
Total Cash491M212M232%
Total Debt16M204M8%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMTXPHAT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OFAVX25.130.07
+0.28%
Olstein All Cap Value A
RISIX12.580.03
+0.24%
RBC International Small Cap Equity I
LGCYX17.250.01
+0.06%
Lord Abbett Global Equity I
OTCNX67.52-0.15
-0.22%
Invesco Discovery Large Cap R
FBTAX24.02-0.47
-1.92%
Fidelity Advisor Biotechnology A

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with RCKT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-2.30%
RCKT - IMTX
45%
Loosely correlated
-0.71%
MRUS - IMTX
44%
Loosely correlated
-4.37%
CGON - IMTX
42%
Loosely correlated
-1.62%
ROIV - IMTX
42%
Loosely correlated
-3.54%
INZY - IMTX
42%
Loosely correlated
-7.26%
More